Paul Tudor Jones’s Disc Medicine IRON Stock Holding History

Paul Tudor Jones’s Portfolio IRON Stock Details IRON Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$2.1M	Sell	28,663 -2,339	-8%	-$161K	﹤0.01%	1915
2026 Q1	$1.98M	Sell	31,002 -35,123	-53%	-$2.44M	﹤0.01%	1866
2025 Q4	$5.25M	Buy	+66,125	New	+$5.59M	0.01%	1127
2025 Q1	–	Sell	-13,353	Closed	-$847K	–	3325
2024 Q4	$847K	Buy	+13,353	New	+$772K	﹤0.01%	1847
2024 Q2	–	Sell	-13,488	Closed	-$840K	–	2542
2024 Q1	$840K	Buy	+13,488	New	+$875K	0.01%	1414
2023 Q3	–	Sell	-12,335	Closed	-$548K	–	2564
2023 Q2	$548K	Buy	+12,335	New	+$438K	0.01%	1664

Other funds holding IRON

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

RCM

RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

VPC

Vestal Point Capital New York $4.28B AUM 239% 1-Year Est. Return

AVLSA

Atlas Venture Life Science Advisors Cambridge, Massachusetts $881M AUM 160.77% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Paul Tudor Jones's IRON Position: Q2 2026 in Review

Paul Tudor Jones reduced its Disc Medicine (IRON) stake by 7.5% in Q2 2026, selling an estimated $161K and leaving 28,663 shares worth $2.1M. The position accounts for ﹤0.01% of the portfolio, ranked #1915.

Paul Tudor Jones first reported a position in IRON in Q2 2023 and has held it in 6 quarters since. The position peaked at $5.25M in Q4 2025. 215 funds tracked by Wall St. Rank hold IRON as of Q2 2026.

Paul Tudor Jones held 28,663 shares of Disc Medicine worth $2.1M as of Q2 2026.
Paul Tudor Jones sold 2,339 Disc Medicine shares in Q2 2026, an estimated $161K.
Disc Medicine made up ﹤0.01% of Paul Tudor Jones's portfolio in Q2 2026, its #1915 holding.
Paul Tudor Jones first reported a position in Disc Medicine in Q2 2023 and has held it in 6 quarters since.
Paul Tudor Jones's Disc Medicine position peaked at $5.25M in Q4 2025.
215 funds tracked by Wall St. Rank held Disc Medicine as of Q2 2026.

Based on Tudor Investment Corp's 13F filing for Q2 2026, filed 14 Aug 2026.